<DOC>
	<DOC>NCT01950260</DOC>
	<brief_summary>The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).</brief_summary>
	<brief_title>Early Levothyroxine Post Radioactive Iodine</brief_title>
	<detailed_description />
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Graves Disease</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>Inclusion criteria target all adult patients (ages 1870 years) with GD who will receive RAI for treatment of GD. Patient with clinically manifest GO will be excluded from the study. We will also exclude patients with recent (&lt;1 yr.) history of arrhythmias or any history of ventricular arrhythmias, those with preexistent cardiomyopathy, those with malnutrition and those with psychiatric history that could get worse if patient remains persistently hyperthyroid. Patients unlikely to return for the planned followup visits, to comply with the blood drawing schedule and with the completion of the hypothyroidHDQL and TQS questionnaires will also be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Graves' disease</keyword>
	<keyword>Radioactive iodine</keyword>
	<keyword>Hypothyroidism</keyword>
</DOC>